<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BA9BFCD1-C860-4387-B150-BD302EFE4049"><gtr:id>BA9BFCD1-C860-4387-B150-BD302EFE4049</gtr:id><gtr:name>Free University of Berlin</gtr:name><gtr:address><gtr:line1>Kaiserswerther Str. 16-18</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/425C1994-4AF3-4F87-AA91-B980EF37664C"><gtr:id>425C1994-4AF3-4F87-AA91-B980EF37664C</gtr:id><gtr:name>University at Buffalo</gtr:name><gtr:address><gtr:line1>12 Capen Hall</gtr:line1><gtr:postCode>14260</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Neuroscience Physiology and Pharmacology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BA9BFCD1-C860-4387-B150-BD302EFE4049"><gtr:id>BA9BFCD1-C860-4387-B150-BD302EFE4049</gtr:id><gtr:name>Free University of Berlin</gtr:name><gtr:address><gtr:line1>Kaiserswerther Str. 16-18</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/425C1994-4AF3-4F87-AA91-B980EF37664C"><gtr:id>425C1994-4AF3-4F87-AA91-B980EF37664C</gtr:id><gtr:name>University at Buffalo</gtr:name><gtr:address><gtr:line1>12 Capen Hall</gtr:line1><gtr:postCode>14260</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D792CC11-5259-4B4A-9F3F-097BF56072F8"><gtr:id>D792CC11-5259-4B4A-9F3F-097BF56072F8</gtr:id><gtr:firstName>Josef</gtr:firstName><gtr:otherNames>Thomas</gtr:otherNames><gtr:surname>Kittler</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G120%2F972"><gtr:id>149F8A26-D862-4E0A-B037-BB9F7E9A30E6</gtr:id><gtr:title>Regulation of synaptic inhibition under normal conditions and in ischaemia and neurodegenerative disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G120/972</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Synaptic inhibition, mediated by the -aminobutyric acid type A receptor (GABAAR), a ligand-gated chloride channel, is crucial for the control of cell and network activity in the brain. Modulating GABAAR function has major consequences for neuronal excitation and information processing in the brain. In addition, altered GABAAR function has been implicated in an increasing number of neurological and neuropsychiatric diseases. Understanding the molecular mechanisms neurons use to regulate GABAAR function will have important implications for both our understanding of how neuronal activity is controlled and how disrupted inhibition may contribute to the pathogenesis of diseases such as epilepsy, stroke, anxiety, substance abuse, depression, Parkinson?s disease and autism. One accepted means of modifying the efficacy of synaptic transmission is to change the number and/or sensitivity of postsynaptic receptors. This can be achieved by a number of mechanisms, including regulated receptor membrane trafficking, and post-translational modifications such as phosphorylation, ubiquitination or palmitoylation. The overall aim of my research is to understand better the molecular mechanisms important for regulating GABAAR function, with a particular emphasis on control of GABAAR membrane trafficking and how this may be altered under pathological conditions such as ischaemia and neurodegeneration. The main objectives of my proposal are to investigate three distinct but related questions:
(1) How do glutamate signalling and ischaemia modulate GABAAR activity, surface dynamics and membrane trafficking?
(2) What is the role of the huntingtin associated protein 1 (HAP1) in GABAAR membrane trafficking?
(3) Does disrupted HAP1 function lead to altered GABAAR activity in Huntington?s disease (HD)?
Completion of this work will provide valuable insights into how GABAAR function and synaptic inhibition are controlled under normal conditions, and how altered inhibitory neurotransmitter ptor function and trafficking may contribute to neuronal dysfunction in stroke and neurodegenerative disease. 
To answer these questions, I will use a multi-disciplinary approach combining molecular, cell biological, biochemical, imaging and electrophysiological methodologies.</gtr:technicalSummary><gtr:fund><gtr:end>2009-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>587703</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Pfizer</gtr:description><gtr:id>57FEA421-1453-4B46-9D10-07ED801712D3</gtr:id><gtr:impact>Commitment from Pfizer to financial support and provision of proprietary reagents for future work in form of MRC case studentship application - pending</gtr:impact><gtr:outcomeId>rf9ueFJpA18-1</gtr:outcomeId><gtr:partnerContribution>Commitment to financial support and provision of proprietary reagents for future work in form of MRC case studentship application - pending.</gtr:partnerContribution><gtr:piContribution>Expertise in imaging and neurobiology</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Biosciences</gtr:department><gtr:description>Imaging receptor membrane dynamics with Quantum Dots</gtr:description><gtr:id>0A3B433F-616D-46F7-9745-A55A7663D23B</gtr:id><gtr:impact>Data from this collaboration has been presented at several international meetings. Data currently being written up for publication. The methods derived from this collaboration directly contributed to a successful application for an MRC Senior Non-Clinical Fellowship</gtr:impact><gtr:outcomeId>616832E4F39-1</gtr:outcomeId><gtr:partnerContribution>Provided novel methods for acquisition and analysis of ion channels at the membrane of nerve cell labelled with semi conductor nanocrystals</gtr:partnerContribution><gtr:piContribution>Lead research on receptor membrane dynamics in nerve cell membranes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Free University of Berlin</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Department of Biochemistry</gtr:department><gtr:description>Molecular determinants of ion channel interaction with AP2</gtr:description><gtr:id>E9A7328F-650D-4B0D-B1C9-78A4E45B8039</gtr:id><gtr:impact>Lead to invitations to present research at several institutions and to several publications in leading journals (e.g. Kittler et al 2008; Kastning et al 2007). Additional data is currently being written up for publication. This work also directly contributed to a successful application for an MRC senior non-clinical fellowship.</gtr:impact><gtr:outcomeId>A60AEB26626-1</gtr:outcomeId><gtr:partnerContribution>Contributed reagents, biochemical analysis and x-ray crystallography expertise</gtr:partnerContribution><gtr:piContribution>Lead research project to identify molecular determinants of interaction between GABA-A receptor and the clathrin adaptor AP2 (Kittler et al., 2008). Contributed to research project on identification of molecular determinants of AMPA receptor interaction with AP2 (Kastning et al., 2007).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University at Buffalo</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Physiology and Biophysics</gtr:department><gtr:description>Physiological role of GABA-A and glutamate receptor plasma membrane endocytosis</gtr:description><gtr:id>C2963C11-81EB-4AD0-83BC-325C7781CC1E</gtr:id><gtr:impact>Lead to invitations to present research at several institutions and to several publications in leading journals (e.g. Kittler et al 2008; Kastning et al 2007). Additional data is currently being written up for publication. This work also directly contributed to a successful application for an MRC senior non-clinical fellowship.</gtr:impact><gtr:outcomeId>4C1C2CC8816-1</gtr:outcomeId><gtr:partnerContribution>Provided expertise in electrophysiological analysis of synaptic transmission.</gtr:partnerContribution><gtr:piContribution>Lead research project on GABA-A receptor endocytosis and it's physiological consequences for synaptic transmission (Kittler et al., 2008). Contributed to research project on study of physiological role of AMPA receptor internalisation for synaptic transmission (Kastning et al., 2007).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Website dissemination</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0CD0E15F-555B-43E9-A0C8-E20DF02478D4</gtr:id><gtr:impact>Our work was also showcased in the MRC News section of the MRC website (see (http://www.mrc.ac.uk/Newspublications/News/MRC005717).

Led to work being promoted by UCL Neurosciences promotion of brain awareness week.</gtr:impact><gtr:outcomeId>7315307D925</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Website dissemination</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AA5AE819-7FB4-43BA-9090-677991EB0566</gtr:id><gtr:impact>'UCL neuroscience' (www.ucl.ac.uk/neuroscience) which brings together neuroscience research at UCL has a very active public engagement policy. UCL was recently named one of the six 'Beacons of Public Engagement' nationwide. As part of UCL Neurosciences promotion of brain awareness week 2009, UCL neuroscience showcased work from several labs including our work 'Brain power where it is needed' as part of the 'latest breakthroughs' for UCL neuroscience (see http://www.ucl.ac.uk/news/news-articles/0903/09031604).

NA</gtr:impact><gtr:outcomeId>729895D0311</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society Research Grant</gtr:description><gtr:end>2007-01-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>1E1EEB87-9857-41B7-B32C-86C171B955B5</gtr:id><gtr:outcomeId>jJuvcxxTct70</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Senior Non-Clinical Fellowship</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0802377</gtr:fundingRef><gtr:id>856202EF-48E3-4CFA-A31D-5F928C5536DA</gtr:id><gtr:outcomeId>62EDDAF93430</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Funding allowed the establishment in my group of state of analysis approaches 9in collaboration with Dr Lewis Griffin) to analyse imaging data of single neurotransmitter receptors in the plasma membrane of nerve cells imaged using Quantum Dots.</gtr:description><gtr:id>FE95C09F-6C80-44C4-9819-9B6F347601AB</gtr:id><gtr:impact>lead to additional MRC fellowship funding</gtr:impact><gtr:outcomeId>122D6625CB5</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Analysis of Quantum Dot tracking</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Funding allowed the establishment in my group of state of the art imaging approaches to study the behavior of single neurotransmitter receptors in the plasma membrane of nerve cells. These approaches used novel technologies such as semi conductor nanocrystals (Quantum Dots).</gtr:description><gtr:id>60D162D7-AB3A-491F-83ED-24E0CE7E901B</gtr:id><gtr:impact>The establishment of these approaches during the tenure of my MRC Career Development Award was a direct contributor to my successful application for an MRC Senior-Non Clinical Fellowship.</gtr:impact><gtr:outcomeId>303F294A986</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Imaging with Quantum Dots</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>51725F80-EE59-45BB-B6EA-6DEABA1227D8</gtr:id><gtr:title>Regulation of inhibitory synaptic transmission by a conserved atypical interaction of GABA(A) receptor beta- and gamma-subunits with the clathrin AP2 adaptor.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3375e9a835923724668c6c34d1f7707"><gtr:id>e3375e9a835923724668c6c34d1f7707</gtr:id><gtr:otherNames>Smith KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>C44EF7216D7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CFE9F7CB-5BFA-48C7-AF4E-C8E6CD42D738</gtr:id><gtr:title>Regulation of GABA(A) receptor membrane trafficking and synaptic localization.</gtr:title><gtr:parentPublicationTitle>Pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c7ca64b87eec214d6deaec9a39a152d"><gtr:id>6c7ca64b87eec214d6deaec9a39a152d</gtr:id><gtr:otherNames>Arancibia-C?rcamo IL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0163-7258</gtr:issn><gtr:outcomeId>Jo8A1JP7e77</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1F9DC95-C5DC-400B-B568-14E20E1713DF</gtr:id><gtr:title>Regulation of synaptic inhibition by phospho-dependent binding of the AP2 complex to a YECL motif in the GABAA receptor gamma2 subunit.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b917950003555246b9239fd4c156c05"><gtr:id>8b917950003555246b9239fd4c156c05</gtr:id><gtr:otherNames>Kittler JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>35F756DA34B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E541235-820F-4CD1-A92E-5115A359169C</gtr:id><gtr:title>Gephyrin regulates the cell surface dynamics of synaptic GABAA receptors.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0f6b13f111df15eff24fcfbf697b8e2"><gtr:id>d0f6b13f111df15eff24fcfbf697b8e2</gtr:id><gtr:otherNames>Jacob TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>B17FA898A29</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17B8B1D2-A650-45C1-ABDB-6FC353A8D83B</gtr:id><gtr:title>Deficits in phosphorylation of GABA(A) receptors by intimately associated protein kinase C activity underlie compromised synaptic inhibition during status epilepticus.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d0e6628deeb5c98efa876e7b3da27ea"><gtr:id>1d0e6628deeb5c98efa876e7b3da27ea</gtr:id><gtr:otherNames>Terunuma M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>58ca44a54a0f69.58824704</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FB1494F-F443-42CD-B6E5-BE492817186E</gtr:id><gtr:title>Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fe6a472b218867243ba40a366925fc1"><gtr:id>9fe6a472b218867243ba40a366925fc1</gtr:id><gtr:otherNames>Macaskill AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>60D5744A716</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA49B841-6231-4791-8D82-B61AAC527846</gtr:id><gtr:title>Ubiquitin-dependent lysosomal targeting of GABA(A) receptors regulates neuronal inhibition.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c7ca64b87eec214d6deaec9a39a152d"><gtr:id>6c7ca64b87eec214d6deaec9a39a152d</gtr:id><gtr:otherNames>Arancibia-C?rcamo IL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>8467E6C96FA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EF12F32-9B88-4CF3-BB72-65BC7F73301B</gtr:id><gtr:title>Molecular determinants for the interaction between AMPA receptors and the clathrin adaptor complex AP-2.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c1455c35584b0e573472e0ce5cc6c64"><gtr:id>6c1455c35584b0e573472e0ce5cc6c64</gtr:id><gtr:otherNames>Kastning K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>210BB5ECB65</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F8C58AD-D426-4712-A950-5917CFC975E7</gtr:id><gtr:title>Dopamine D3 receptors regulate GABAA receptor function through a phospho-dependent endocytosis mechanism in nucleus accumbens.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7049ab5b9b59ba3f8cbf79b761c1402"><gtr:id>c7049ab5b9b59ba3f8cbf79b761c1402</gtr:id><gtr:otherNames>Chen G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>982FA481B09</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>712DE7A4-0E98-4A41-AB23-5A12ECD03BB5</gtr:id><gtr:title>Phospholipase C-related inactive protein is implicated in the constitutive internalization of GABAA receptors mediated by clathrin and AP2 adaptor complex.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be855dc6d3e2ff80c3fdcb3c11c37641"><gtr:id>be855dc6d3e2ff80c3fdcb3c11c37641</gtr:id><gtr:otherNames>Kanematsu T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>857BADF6631</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>640AF6F1-2F35-4AF9-B1CC-E29CD41AEBF8</gtr:id><gtr:title>Censoring the editor in transient forebrain ischemia.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b917950003555246b9239fd4c156c05"><gtr:id>8b917950003555246b9239fd4c156c05</gtr:id><gtr:otherNames>Kittler JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>B9F48E6DF3A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C4C9567-2EEF-4BAB-8AA7-4F7C16E8D7DD</gtr:id><gtr:title>Modulation of GABA(A) receptor phosphorylation and membrane trafficking by phospholipase C-related inactive protein/protein phosphatase 1 and 2A signaling complex underlying brain-derived neurotrophic factor-dependent regulation of GABAergic inhibition.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be855dc6d3e2ff80c3fdcb3c11c37641"><gtr:id>be855dc6d3e2ff80c3fdcb3c11c37641</gtr:id><gtr:otherNames>Kanematsu T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>1EEB0822ABD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B4945FA-6A29-4D81-8F69-12C763E2557E</gtr:id><gtr:title>GTPase dependent recruitment of Grif-1 by Miro1 regulates mitochondrial trafficking in hippocampal neurons.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b47a4311b842d7252f7aaef68365931"><gtr:id>5b47a4311b842d7252f7aaef68365931</gtr:id><gtr:otherNames>MacAskill AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1044-7431</gtr:issn><gtr:outcomeId>B6079E0D8E7</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G120/972</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>